Scilex Holding SCLX
NASDAQ SCLX
$5.73 -0.07 (-1.21%)
At close: Aug 21, 2026 · 4:00 PM EDT

Scilex Holding (SCLX) Change in Account Payables (2022 - 2026)

Scilex Holding (SCLX) posted quarterly Change in Account Payables of $15.8 million for Q1 2026, up 208.35% year-over-year from $5.1 million in Q1 2025, and up 794.34% quarter-over-quarter from $1.8 million in Q4 2025.

Scilex Holding (SCLX) Change in Account Payables (2022 - 2026) Analysis & Trends

Scilex Holding's Change in Account Payables history runs 5 years deep, the most recent figure standing at $15.8 million for Q1 2026.

  • In Q1 2026, Change in Account Payables rose 208.35% year-over-year to $15.8 million; the TTM figure through Mar 2026 stood at $23.8 million (up 111.0% YoY), while the FY2025 annual figure was $13.1 million, up 76.86% from the prior year.
  • Change in Account Payables for Q1 2026 stood at $15.8 million, up from $1.8 million in the prior quarter.
  • The five-year high for Change in Account Payables was $15.8 million in Q1 2026, with the low at -$612000.0 in Q2 2024.
  • The 5-year median for Change in Account Payables is $2.0 million (2023), against an average of $3.5 million.
  • The sharpest annual moves came in 2023 and 2024: Change in Account Payables jumped 5313.66% in 2023, then plunged 126.23% in 2024.
  • Scilex Holding's Change in Account Payables stood at -$161000.0 in 2022, then surged by 5313.66% to $8.4 million in 2023, then tumbled by 38.61% to $5.2 million in 2024, then plunged by 65.69% to $1.8 million in 2025, then surged by 794.34% to $15.8 million in 2026.
  • Business Quant data shows SCLX's Change in Account Payables at $15.8 million in Q1 2026, $1.8 million in Q4 2025, and $4.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn -
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn -
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn -
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn -
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn -
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn -70.00 Mn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn 18.00 Mn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn -
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn -
10 Scilex Holding 39.22 Mn -73.57 Mn 3.97 Mn 3.78 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 15.81 Mn
Mar 31, 2026 15.81 Mn
Dec 31, 2025 1.77 Mn
Dec 31, 2025 1.77 Mn
Sep 30, 2025 4.50 Mn
Sep 30, 2025 4.50 Mn
Jun 30, 2025 1.73 Mn
Jun 30, 2025 1.73 Mn
Mar 31, 2025 5.13 Mn
Mar 31, 2025 5.13 Mn
Dec 31, 2024 5.15 Mn
Dec 31, 2024 5.15 Mn
Sep 30, 2024 1.61 Mn
Sep 30, 2024 1.61 Mn
Jun 30, 2024 -612,000.00
Jun 30, 2024 -612,000.00
Mar 31, 2024 1.27 Mn
Mar 31, 2024 1.27 Mn
Dec 31, 2023 8.39 Mn
Dec 31, 2023 8.39 Mn